These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neonatal malformations and hormone therapy during pregnancy]. Pacilli L; Graffino W; Arrotta S Minerva Ginecol; 1981; 33(7-8):659-65. PubMed ID: 7290498 [TBL] [Abstract][Full Text] [Related]
4. Letter: Oral contraceptives and congenital limb-reduction defects. Kay CR N Engl J Med; 1975 Jan; 292(5):267-8. PubMed ID: 1110701 [TBL] [Abstract][Full Text] [Related]
5. Maternal exposure to exogenous progestogen/estrogen as a potential cause of birth defects. Nora AH; Nora JJ Adv Plan Parent; 1978; 12(3):156-69. PubMed ID: 640221 [No Abstract] [Full Text] [Related]
6. Editorial: Are sex hormones teratogenic? Lancet; 1974 Dec; 2(7895):1489-90. PubMed ID: 4140400 [No Abstract] [Full Text] [Related]
7. Oral contraceptives and congenital limb defects. Can Med Assoc J; 1975 Mar; 112(5):551. PubMed ID: 1116074 [No Abstract] [Full Text] [Related]
8. Exogenous female sex hormones and birth defects. Polednak AP Public Health Rev; 1985; 13(1-2):89-114. PubMed ID: 2939493 [No Abstract] [Full Text] [Related]
11. Pill taken during or just before pregnancy not linked to various birth defects; need more study on heart ills. Fam Plann Perspect; 1977; 9(3):132-3. PubMed ID: 862834 [TBL] [Abstract][Full Text] [Related]
12. Are female sex hormones teratogenic? Wilson JG; Brent RL Am J Obstet Gynecol; 1981 Nov; 141(5):567-80. PubMed ID: 6271011 [TBL] [Abstract][Full Text] [Related]
13. Exogenous sex hormone exposure and the risk for VACTERL association. Lammer EJ; Cordero JF; Khoury MJ Teratology; 1986 Oct; 34(2):165-9. PubMed ID: 3775669 [TBL] [Abstract][Full Text] [Related]
16. Sex hormones and congenital malformations: a review. Nelson KG; Goldenberg RL J Med Assoc State Ala; 1977 May; 46(11):31. PubMed ID: 864346 [TBL] [Abstract][Full Text] [Related]
17. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Bracken MB Obstet Gynecol; 1990 Sep; 76(3 Pt 2):552-7. PubMed ID: 2143279 [TBL] [Abstract][Full Text] [Related]
18. Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Waller DK; Gallaway MS; Taylor LG; Ramadhani TA; Canfield MA; Scheuerle A; Hernández-Diaz S; Louik C; Correa A; Epidemiology; 2010 Mar; 21(2):232-9. PubMed ID: 20087193 [TBL] [Abstract][Full Text] [Related]
19. A syndrome of multiple congenital anomalies associated with teratogenic exposure. Nora AH; Nora JJ Arch Environ Health; 1975 Jan; 30(1):17-21. PubMed ID: 1109267 [TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]